Clinical trial

Evaluation of MolecuLight i:X as an Adjunctive Fluorescence Imaging Tool to…

NCT03540004 · MolecuLight Inc., Industry · Unknown status

Key facts

NCT number NCT03540004
Title Evaluation of MolecuLight i:X as an Adjunctive Fluorescence Imaging Tool to Clinical Signs and Symptoms for the Identification of Bacteria-containing Wounds
Official title A Prospective, Single-blind, Multi-center Clinical Study Evaluating the Use of MolecuLight i:X as an Adjunctive Fluorescence Imaging Tool to Clinical Signs and Symptoms for the Identification of Bacteria-containing Wounds.
Lead sponsor MolecuLight Inc., Industry
Collaborators SerenaGroup, Inc.
Status Unknown status
Study type Observational
Conditions Wound
Intervention type Device
Interventions MolecuLight i:X Imaging Device
Enrollment 367
Start date May 23, 2018
Primary completion Apr 9, 2019
Completion Dec 30, 2020
First posted May 30, 2018
Last update posted Mar 6, 2020
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies